Global Hepatitis A Vaccine Supply, Demand and Key Producers, 2024-2030

Description

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.  Two types of HAV vaccines are currently available internationally:  1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).  2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

The global Hepatitis A Vaccine market size is expected to reach $ 880 million by 2030, rising at a market growth of 2.2% CAGR during the forecast period (2024-2030).

The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.

Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific  is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%.  In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.

This report studies the global Hepatitis A Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hepatitis A Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hepatitis A Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hepatitis A Vaccine total production and demand, 2019-2030, (K Unit)
Global Hepatitis A Vaccine total production value, 2019-2030, (USD Million)
Global Hepatitis A Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Unit), (based on production site)
Global Hepatitis A Vaccine consumption by region & country, CAGR, 2019-2030 & (K Unit)
U.S. VS China: Hepatitis A Vaccine domestic production, consumption, key domestic manufacturers and share
Global Hepatitis A Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Unit)
Global Hepatitis A Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Unit)
Global Hepatitis A Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Unit)
This report profiles key players in the global Hepatitis A Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hepatitis A Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Unit) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hepatitis A Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hepatitis A Vaccine Market, Segmentation by Type:
    Inactivated Vaccine
    Live Attenuated Vaccine

Global Hepatitis A Vaccine Market, Segmentation by Application:
    Government Institution
    Private Sector
    Other

Companies Profiled:
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    Convac

Key Questions Answered:
1. How big is the global Hepatitis A Vaccine market?
2. What is the demand of the global Hepatitis A Vaccine market?
3. What is the year over year growth of the global Hepatitis A Vaccine market?
4. What is the production and production value of the global Hepatitis A Vaccine market?
5. Who are the key producers in the global Hepatitis A Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hepatitis A Vaccine Introduction
    1.2 World Hepatitis A Vaccine Supply & Forecast
        1.2.1 World Hepatitis A Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Hepatitis A Vaccine Production (2019-2030)
        1.2.3 World Hepatitis A Vaccine Pricing Trends (2019-2030)
    1.3 World Hepatitis A Vaccine Production by Region (Based on Production Site)
        1.3.1 World Hepatitis A Vaccine Production Value by Region (2019-2030)
        1.3.2 World Hepatitis A Vaccine Production by Region (2019-2030)
        1.3.3 World Hepatitis A Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Hepatitis A Vaccine Production (2019-2030)
        1.3.5 Europe Hepatitis A Vaccine Production (2019-2030)
        1.3.6 China Hepatitis A Vaccine Production (2019-2030)
        1.3.7 Japan Hepatitis A Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hepatitis A Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hepatitis A Vaccine Major Market Trends

2 Demand Summary
    2.1 World Hepatitis A Vaccine Demand (2019-2030)
    2.2 World Hepatitis A Vaccine Consumption by Region
        2.2.1 World Hepatitis A Vaccine Consumption by Region (2019-2024)
        2.2.2 World Hepatitis A Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Hepatitis A Vaccine Consumption (2019-2030)
    2.4 China Hepatitis A Vaccine Consumption (2019-2030)
    2.5 Europe Hepatitis A Vaccine Consumption (2019-2030)
    2.6 Japan Hepatitis A Vaccine Consumption (2019-2030)
    2.7 South Korea Hepatitis A Vaccine Consumption (2019-2030)
    2.8 ASEAN Hepatitis A Vaccine Consumption (2019-2030)
    2.9 India Hepatitis A Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Hepatitis A Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Hepatitis A Vaccine Production by Manufacturer (2019-2024)
    3.3 World Hepatitis A Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Hepatitis A Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Hepatitis A Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Hepatitis A Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Hepatitis A Vaccine in 2023
    3.6 Hepatitis A Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Hepatitis A Vaccine Market: Region Footprint
        3.6.2 Hepatitis A Vaccine Market: Company Product Type Footprint
        3.6.3 Hepatitis A Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Hepatitis A Vaccine Production Value Comparison
        4.1.1 United States VS China: Hepatitis A Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Hepatitis A Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Hepatitis A Vaccine Production Comparison
        4.2.1 United States VS China: Hepatitis A Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hepatitis A Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Hepatitis A Vaccine Consumption Comparison
        4.3.1 United States VS China: Hepatitis A Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Hepatitis A Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Hepatitis A Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Hepatitis A Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Hepatitis A Vaccine Production (2019-2024)
    4.5 China Based Hepatitis A Vaccine Manufacturers and Market Share
        4.5.1 China Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Hepatitis A Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Hepatitis A Vaccine Production (2019-2024)
    4.6 Rest of World Based Hepatitis A Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Hepatitis A Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Hepatitis A Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Hepatitis A Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Inactivated Vaccine
        5.2.2 Live Attenuated Vaccine
    5.3 Market Segment by Type
        5.3.1 World Hepatitis A Vaccine Production by Type (2019-2030)
        5.3.2 World Hepatitis A Vaccine Production Value by Type (2019-2030)
        5.3.3 World Hepatitis A Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hepatitis A Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Government Institution
        6.2.2 Private Sector
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Hepatitis A Vaccine Production by Application (2019-2030)
        6.3.2 World Hepatitis A Vaccine Production Value by Application (2019-2030)
        6.3.3 World Hepatitis A Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Hepatitis A Vaccine Product and Services
        7.1.4 GSK Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 Merck
        7.2.1 Merck Details
        7.2.2 Merck Major Business
        7.2.3 Merck Hepatitis A Vaccine Product and Services
        7.2.4 Merck Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Merck Recent Developments/Updates
        7.2.6 Merck Competitive Strengths & Weaknesses
    7.3 Sanofi
        7.3.1 Sanofi Details
        7.3.2 Sanofi Major Business
        7.3.3 Sanofi Hepatitis A Vaccine Product and Services
        7.3.4 Sanofi Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Sanofi Recent Developments/Updates
        7.3.6 Sanofi Competitive Strengths & Weaknesses
    7.4 Sinovac
        7.4.1 Sinovac Details
        7.4.2 Sinovac Major Business
        7.4.3 Sinovac Hepatitis A Vaccine Product and Services
        7.4.4 Sinovac Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Sinovac Recent Developments/Updates
        7.4.6 Sinovac Competitive Strengths & Weaknesses
    7.5 Zhejiang Pukang
        7.5.1 Zhejiang Pukang Details
        7.5.2 Zhejiang Pukang Major Business
        7.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
        7.5.4 Zhejiang Pukang Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Zhejiang Pukang Recent Developments/Updates
        7.5.6 Zhejiang Pukang Competitive Strengths & Weaknesses
    7.6 Changchun Institute of Biological
        7.6.1 Changchun Institute of Biological Details
        7.6.2 Changchun Institute of Biological Major Business
        7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
        7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Changchun Institute of Biological Recent Developments/Updates
        7.6.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.7 KM Biologics
        7.7.1 KM Biologics Details
        7.7.2 KM Biologics Major Business
        7.7.3 KM Biologics Hepatitis A Vaccine Product and Services
        7.7.4 KM Biologics Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 KM Biologics Recent Developments/Updates
        7.7.6 KM Biologics Competitive Strengths & Weaknesses
    7.8 IMBCAMS
        7.8.1 IMBCAMS Details
        7.8.2 IMBCAMS Major Business
        7.8.3 IMBCAMS Hepatitis A Vaccine Product and Services
        7.8.4 IMBCAMS Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 IMBCAMS Recent Developments/Updates
        7.8.6 IMBCAMS Competitive Strengths & Weaknesses
    7.9 Convac
        7.9.1 Convac Details
        7.9.2 Convac Major Business
        7.9.3 Convac Hepatitis A Vaccine Product and Services
        7.9.4 Convac Hepatitis A Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Convac Recent Developments/Updates
        7.9.6 Convac Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hepatitis A Vaccine Industry Chain
    8.2 Hepatitis A Vaccine Upstream Analysis
        8.2.1 Hepatitis A Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Hepatitis A Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Hepatitis A Vaccine Production Mode
    8.6 Hepatitis A Vaccine Procurement Model
    8.7 Hepatitis A Vaccine Industry Sales Model and Sales Channels
        8.7.1 Hepatitis A Vaccine Sales Model
        8.7.2 Hepatitis A Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Hepatitis A Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Hepatitis A Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Hepatitis A Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Hepatitis A Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World Hepatitis A Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World Hepatitis A Vaccine Production by Region (2019-2024) & (K Unit)
 Table 7. World Hepatitis A Vaccine Production by Region (2025-2030) & (K Unit)
 Table 8. World Hepatitis A Vaccine Production Market Share by Region (2019-2024)
 Table 9. World Hepatitis A Vaccine Production Market Share by Region (2025-2030)
 Table 10. World Hepatitis A Vaccine Average Price by Region (2019-2024) & (USD/Unit)
 Table 11. World Hepatitis A Vaccine Average Price by Region (2025-2030) & (USD/Unit)
 Table 12. Hepatitis A Vaccine Major Market Trends
 Table 13. World Hepatitis A Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Unit)
 Table 14. World Hepatitis A Vaccine Consumption by Region (2019-2024) & (K Unit)
 Table 15. World Hepatitis A Vaccine Consumption Forecast by Region (2025-2030) & (K Unit)
 Table 16. World Hepatitis A Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Hepatitis A Vaccine Producers in 2023
 Table 18. World Hepatitis A Vaccine Production by Manufacturer (2019-2024) & (K Unit)
 Table 19. Production Market Share of Key Hepatitis A Vaccine Producers in 2023
 Table 20. World Hepatitis A Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
 Table 21. Global Hepatitis A Vaccine Company Evaluation Quadrant
 Table 22. World Hepatitis A Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Hepatitis A Vaccine Production Site of Key Manufacturer
 Table 24. Hepatitis A Vaccine Market: Company Product Type Footprint
 Table 25. Hepatitis A Vaccine Market: Company Product Application Footprint
 Table 26. Hepatitis A Vaccine Competitive Factors
 Table 27. Hepatitis A Vaccine New Entrant and Capacity Expansion Plans
 Table 28. Hepatitis A Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China Hepatitis A Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Hepatitis A Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Unit)
 Table 31. United States VS China Hepatitis A Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Unit)
 Table 32. United States Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Hepatitis A Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Hepatitis A Vaccine Production (2019-2024) & (K Unit)
 Table 36. United States Based Manufacturers Hepatitis A Vaccine Production Market Share (2019-2024)
 Table 37. China Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Hepatitis A Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Hepatitis A Vaccine Production, (2019-2024) & (K Unit)
 Table 41. China Based Manufacturers Hepatitis A Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based Hepatitis A Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Hepatitis A Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Hepatitis A Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Hepatitis A Vaccine Production, (2019-2024) & (K Unit)
 Table 46. Rest of World Based Manufacturers Hepatitis A Vaccine Production Market Share (2019-2024)
 Table 47. World Hepatitis A Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Hepatitis A Vaccine Production by Type (2019-2024) & (K Unit)
 Table 49. World Hepatitis A Vaccine Production by Type (2025-2030) & (K Unit)
 Table 50. World Hepatitis A Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Hepatitis A Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Hepatitis A Vaccine Average Price by Type (2019-2024) & (USD/Unit)
 Table 53. World Hepatitis A Vaccine Average Price by Type (2025-2030) & (USD/Unit)
 Table 54. World Hepatitis A Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Hepatitis A Vaccine Production by Application (2019-2024) & (K Unit)
 Table 56. World Hepatitis A Vaccine Production by Application (2025-2030) & (K Unit)
 Table 57. World Hepatitis A Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Hepatitis A Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Hepatitis A Vaccine Average Price by Application (2019-2024) & (USD/Unit)
 Table 60. World Hepatitis A Vaccine Average Price by Application (2025-2030) & (USD/Unit)
 Table 61. GSK Basic Information, Manufacturing Base and Competitors
 Table 62. GSK Major Business
 Table 63. GSK Hepatitis A Vaccine Product and Services
 Table 64. GSK Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. GSK Recent Developments/Updates
 Table 66. GSK Competitive Strengths & Weaknesses
 Table 67. Merck Basic Information, Manufacturing Base and Competitors
 Table 68. Merck Major Business
 Table 69. Merck Hepatitis A Vaccine Product and Services
 Table 70. Merck Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Merck Recent Developments/Updates
 Table 72. Merck Competitive Strengths & Weaknesses
 Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 74. Sanofi Major Business
 Table 75. Sanofi Hepatitis A Vaccine Product and Services
 Table 76. Sanofi Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Sanofi Recent Developments/Updates
 Table 78. Sanofi Competitive Strengths & Weaknesses
 Table 79. Sinovac Basic Information, Manufacturing Base and Competitors
 Table 80. Sinovac Major Business
 Table 81. Sinovac Hepatitis A Vaccine Product and Services
 Table 82. Sinovac Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Sinovac Recent Developments/Updates
 Table 84. Sinovac Competitive Strengths & Weaknesses
 Table 85. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
 Table 86. Zhejiang Pukang Major Business
 Table 87. Zhejiang Pukang Hepatitis A Vaccine Product and Services
 Table 88. Zhejiang Pukang Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Zhejiang Pukang Recent Developments/Updates
 Table 90. Zhejiang Pukang Competitive Strengths & Weaknesses
 Table 91. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
 Table 92. Changchun Institute of Biological Major Business
 Table 93. Changchun Institute of Biological Hepatitis A Vaccine Product and Services
 Table 94. Changchun Institute of Biological Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Changchun Institute of Biological Recent Developments/Updates
 Table 96. Changchun Institute of Biological Competitive Strengths & Weaknesses
 Table 97. KM Biologics Basic Information, Manufacturing Base and Competitors
 Table 98. KM Biologics Major Business
 Table 99. KM Biologics Hepatitis A Vaccine Product and Services
 Table 100. KM Biologics Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. KM Biologics Recent Developments/Updates
 Table 102. KM Biologics Competitive Strengths & Weaknesses
 Table 103. IMBCAMS Basic Information, Manufacturing Base and Competitors
 Table 104. IMBCAMS Major Business
 Table 105. IMBCAMS Hepatitis A Vaccine Product and Services
 Table 106. IMBCAMS Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. IMBCAMS Recent Developments/Updates
 Table 108. IMBCAMS Competitive Strengths & Weaknesses
 Table 109. Convac Basic Information, Manufacturing Base and Competitors
 Table 110. Convac Major Business
 Table 111. Convac Hepatitis A Vaccine Product and Services
 Table 112. Convac Hepatitis A Vaccine Production (K Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Convac Recent Developments/Updates
 Table 114. Convac Competitive Strengths & Weaknesses
 Table 115. Global Key Players of Hepatitis A Vaccine Upstream (Raw Materials)
 Table 116. Global Hepatitis A Vaccine Typical Customers
 Table 117. Hepatitis A Vaccine Typical Distributors


List of Figures
 Figure 1. Hepatitis A Vaccine Picture
 Figure 2. World Hepatitis A Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Hepatitis A Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Hepatitis A Vaccine Production (2019-2030) & (K Unit)
 Figure 5. World Hepatitis A Vaccine Average Price (2019-2030) & (USD/Unit)
 Figure 6. World Hepatitis A Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World Hepatitis A Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America Hepatitis A Vaccine Production (2019-2030) & (K Unit)
 Figure 9. Europe Hepatitis A Vaccine Production (2019-2030) & (K Unit)
 Figure 10. China Hepatitis A Vaccine Production (2019-2030) & (K Unit)
 Figure 11. Japan Hepatitis A Vaccine Production (2019-2030) & (K Unit)
 Figure 12. Hepatitis A Vaccine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 15. World Hepatitis A Vaccine Consumption Market Share by Region (2019-2030)
 Figure 16. United States Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 17. China Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 18. Europe Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 19. Japan Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 20. South Korea Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 21. ASEAN Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 22. India Hepatitis A Vaccine Consumption (2019-2030) & (K Unit)
 Figure 23. Producer Shipments of Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Hepatitis A Vaccine Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Hepatitis A Vaccine Markets in 2023
 Figure 26. United States VS China: Hepatitis A Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Hepatitis A Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Hepatitis A Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Hepatitis A Vaccine Production Market Share 2023
 Figure 30. China Based Manufacturers Hepatitis A Vaccine Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Hepatitis A Vaccine Production Market Share 2023
 Figure 32. World Hepatitis A Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Hepatitis A Vaccine Production Value Market Share by Type in 2023
 Figure 34. Inactivated Vaccine
 Figure 35. Live Attenuated Vaccine
 Figure 36. World Hepatitis A Vaccine Production Market Share by Type (2019-2030)
 Figure 37. World Hepatitis A Vaccine Production Value Market Share by Type (2019-2030)
 Figure 38. World Hepatitis A Vaccine Average Price by Type (2019-2030) & (USD/Unit)
 Figure 39. World Hepatitis A Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Hepatitis A Vaccine Production Value Market Share by Application in 2023
 Figure 41. Government Institution
 Figure 42. Private Sector
 Figure 43. Other
 Figure 44. World Hepatitis A Vaccine Production Market Share by Application (2019-2030)
 Figure 45. World Hepatitis A Vaccine Production Value Market Share by Application (2019-2030)
 Figure 46. World Hepatitis A Vaccine Average Price by Application (2019-2030) & (USD/Unit)
 Figure 47. Hepatitis A Vaccine Industry Chain
 Figure 48. Hepatitis A Vaccine Procurement Model
 Figure 49. Hepatitis A Vaccine Sales Model
 Figure 50. Hepatitis A Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Companies Mentioned

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac